Related content

Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis

By Penning-van Beest Fernie J. A.   Erkens Joëlle A.   Olson M.   Herings Ron M. C.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1337-1344

Informa Healthcare

Access to resources Recommend Favorite

Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis

By Cramer Joyce A.   Silverman Stuart L.   Gold Deborah T.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2369-2377

Informa Healthcare

Access to resources Recommend Favorite

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

By Cramer Joyce A.   Amonkar Mayur M.   Hebborn Ansgar   Altman Roy  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1453-1460

Informa Healthcare

Access to resources Recommend Favorite

Association of hyperhomocysteinemia with osteoporosis: a systematic review

By Salari Pooneh   Larijani Bagher   Abdollahi Mohammad  

Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. : 215-222

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates

By Earnshaw S. R.   Graham C. N.   Ettinger B.   Amonkar M. M.   Lynch N. O.   Middelhoven H.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2517-2529

Informa Healthcare

Access to resources Recommend Favorite